PL370557A1 - Idraparynuks (Sanorg 34006) do leczenia i profilaktyki wtórnej żylnych zdarzeń zakrzepowo-zatorowych u pacjentów z zakrzepicą żył głębokich - Google Patents

Idraparynuks (Sanorg 34006) do leczenia i profilaktyki wtórnej żylnych zdarzeń zakrzepowo-zatorowych u pacjentów z zakrzepicą żył głębokich

Info

Publication number: PL370557A1
Authority: PL; Poland
Prior art keywords: venous; thromboemolic; sanorg; idraparinux; events
Prior art date: 2002-01-29

Application number

PL03370557A

Other languages

English (en)

Other versions

PL207144B1 (pl

Inventor

Amsterdam Ronald Gijsbertus Maria Van

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-29

Filing date

2003-01-23

Publication date

2005-05-30

2003-01-23 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2005-05-30 Publication of PL370557A1 publication Critical patent/PL370557A1/pl

2010-11-30 Publication of PL207144B1 publication Critical patent/PL207144B1/pl

Links

206010051055 Deep vein thrombosis Diseases 0.000 title 1
206010047249 Venous thrombosis Diseases 0.000 title 1
MVPQUSQUURLQKF-MCPDASDXSA-E nonasodium;(2s,3s,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3s,4s,5r,6r)-2-carboxylato-4,5-dimethoxy-6-[(2r,3r,4s,5r,6s)-6-methoxy-4,5-disulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-disulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-4,5-di Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)O[C@@H]1[C@@H](OS([O-])(=O)=O)[C@@H](OC)O[C@H](COS([O-])(=O)=O)[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@@H]2[C@@H]([C@@H](OS([O-])(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](OC)[C@H](O[C@@H]4[C@@H]([C@@H](OC)[C@H](OC)[C@@H](COS([O-])(=O)=O)O4)OC)[C@H](O3)C([O-])=O)OC)[C@@H](COS([O-])(=O)=O)O2)OS([O-])(=O)=O)[C@H](C([O-])=O)O1 MVPQUSQUURLQKF-MCPDASDXSA-E 0.000 title 1
238000011321 prophylaxis Methods 0.000 title 1
238000011282 treatment Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PL370557A 2002-01-29 2003-01-23 Dawka pentasacharydu metylo-O-(2,3,4-tri-O-metylo-6-O-sulfo-α-D-glukopiranozylo)-(1→4)-O-(2,3-di-O-metylo-β-D-glukopiranozylo kwas uronowy)-(1→4)-O-(2,3,6-tri-O-sulfo-α-D-glukopiranozylo)-(1→4)-O-(2,3-di-O-metylo-α-L-idopiranozylo kwas uronowy)-(1→4)-2,3,6-tri-O-sulfo-α-D-glukopiranozydu i jej zastosowanie PL207144B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02075374		2002-01-29

Publications (2)

Publication Number	Publication Date
PL370557A1 true PL370557A1 (pl)	2005-05-30
PL207144B1 PL207144B1 (pl)	2010-11-30

Family

ID=27635850

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL370557A PL207144B1 (pl)	2002-01-29	2003-01-23	Dawka pentasacharydu metylo-O-(2,3,4-tri-O-metylo-6-O-sulfo-α-D-glukopiranozylo)-(1→4)-O-(2,3-di-O-metylo-β-D-glukopiranozylo kwas uronowy)-(1→4)-O-(2,3,6-tri-O-sulfo-α-D-glukopiranozylo)-(1→4)-O-(2,3-di-O-metylo-α-L-idopiranozylo kwas uronowy)-(1→4)-2,3,6-tri-O-sulfo-α-D-glukopiranozydu i jej zastosowanie

Country Status (22)

Country	Link
US (1)	US7709463B2 (pl)
EP (1)	EP1471924B1 (pl)
JP (1)	JP4870907B2 (pl)
CN (1)	CN1622813A (pl)
AR (1)	AR038320A1 (pl)
AT (1)	ATE323497T1 (pl)
AU (1)	AU2003205664B2 (pl)
BR (1)	BR0307196A (pl)
CA (1)	CA2472957C (pl)
CY (1)	CY1107661T1 (pl)
DE (1)	DE60304678T2 (pl)
DK (1)	DK1471924T3 (pl)
EA (1)	EA007204B1 (pl)
ES (1)	ES2262971T3 (pl)
MX (1)	MXPA04007310A (pl)
NO (1)	NO332699B1 (pl)
PE (1)	PE20030855A1 (pl)
PL (1)	PL207144B1 (pl)
PT (1)	PT1471924E (pl)
SI (1)	SI1471924T1 (pl)
TW (1)	TWI281861B (pl)
WO (1)	WO2003063881A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070086865A (ko) *	2004-12-01	2007-08-27	오에스아이 파마슈티컬스, 인코포레이티드	Ｎ-치환된 벤즈이미다졸일 ｃ-ｋｉｔ 억제제 및 조합적인벤즈이미다졸 라이브러리
US9642822B2 (en)	2011-05-27	2017-05-09	Children's Medical Center Corporation	Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
EP3997238A1 (en)	2019-07-09	2022-05-18	Optimvia, LLC	Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5378829A (en) *	1990-04-23	1995-01-03	Akzo N.V.	Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

2003
- 2003-01-14 TW TW092100703A patent/TWI281861B/zh not_active IP Right Cessation
- 2003-01-23 MX MXPA04007310A patent/MXPA04007310A/es active IP Right Grant
- 2003-01-23 SI SI200330334T patent/SI1471924T1/sl unknown
- 2003-01-23 BR BR0307196-0A patent/BR0307196A/pt not_active Application Discontinuation
- 2003-01-23 ES ES03702514T patent/ES2262971T3/es not_active Expired - Lifetime
- 2003-01-23 PL PL370557A patent/PL207144B1/pl unknown
- 2003-01-23 DK DK03702514T patent/DK1471924T3/da active
- 2003-01-23 JP JP2003563570A patent/JP4870907B2/ja not_active Expired - Fee Related
- 2003-01-23 PE PE2003000071A patent/PE20030855A1/es not_active Application Discontinuation
- 2003-01-23 AT AT03702514T patent/ATE323497T1/de active
- 2003-01-23 CN CNA038028123A patent/CN1622813A/zh active Pending
- 2003-01-23 DE DE60304678T patent/DE60304678T2/de not_active Expired - Lifetime
- 2003-01-23 PT PT03702514T patent/PT1471924E/pt unknown
- 2003-01-23 EA EA200400817A patent/EA007204B1/ru not_active IP Right Cessation
- 2003-01-23 AU AU2003205664A patent/AU2003205664B2/en not_active Ceased
- 2003-01-23 EP EP03702514A patent/EP1471924B1/en not_active Expired - Lifetime
- 2003-01-23 US US10/502,706 patent/US7709463B2/en not_active Expired - Fee Related
- 2003-01-23 WO PCT/EP2003/000696 patent/WO2003063881A1/en not_active Ceased
- 2003-01-23 CA CA2472957A patent/CA2472957C/en not_active Expired - Fee Related
- 2003-01-28 AR ARP030100237A patent/AR038320A1/es not_active Application Discontinuation
2004
- 2004-07-27 NO NO20043195A patent/NO332699B1/no not_active IP Right Cessation
2006
- 2006-07-19 CY CY20061101002T patent/CY1107661T1/el unknown

Also Published As

Publication number	Publication date
JP2005519919A (ja)	2005-07-07
PE20030855A1 (es)	2003-10-11
PL207144B1 (pl)	2010-11-30
CY1107661T1 (el)	2013-04-18
DE60304678T2 (de)	2007-04-05
TWI281861B (en)	2007-06-01
EA200400817A1 (ru)	2005-02-24
SI1471924T1 (sl)	2006-10-31
ES2262971T3 (es)	2006-12-01
BR0307196A (pt)	2004-11-03
WO2003063881A1 (en)	2003-08-07
US7709463B2 (en)	2010-05-04
CA2472957A1 (en)	2003-08-07
US20050209175A1 (en)	2005-09-22
AU2003205664B2 (en)	2008-06-05
AR038320A1 (es)	2005-01-12
MXPA04007310A (es)	2004-10-29
ATE323497T1 (de)	2006-05-15
EP1471924B1 (en)	2006-04-19
DK1471924T3 (da)	2006-08-21
DE60304678D1 (de)	2006-05-24
NO332699B1 (no)	2012-12-10
EP1471924A1 (en)	2004-11-03
HK1072361A1 (en)	2005-08-26
CN1622813A (zh)	2005-06-01
PT1471924E (pt)	2006-09-29
NO20043195L (no)	2004-10-29
CA2472957C (en)	2011-09-13
EA007204B1 (ru)	2006-08-25
JP4870907B2 (ja)	2012-02-08
TW200302104A (en)	2003-08-01

Similar Documents

Publication	Publication Date	Title
GB0113119D0 (en)	2001-07-18	Knitted substrate for use in medical bandaging product bandaging product and method of forming the same
AU2002233342A1 (en)	2003-02-27	Implants with FK506 for prophylaxis and treatment of restonoses
ZA200505272B (en)	2006-04-26	Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
IL157577A0 (en)	2004-03-28	Disposable underpants and method of providing the same
AU2003290548A8 (en)	2004-06-07	Prevention and treatment of synucleinopathic disease
EP1461024A4 (en)	2009-03-25	TREATMENT OF WOUNDS AND COMPOSITIONS USED
AU8136801A (en)	2002-02-13	Methods of preventing or treating diseases and conditions using complex carbohydrates
AU2003209851A1 (en)	2003-09-29	Method of treatment and/or prophylaxis
GB9612628D0 (en)	1996-08-21	The use of TCET in the prophylaxis and treatment of allergies
GB2383537B (en)	2003-12-10	Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU2003274963A8 (en)	2004-07-29	Mda-7 and free radicals in the treatment of cancer
SI1471924T1 (sl)	2006-10-31	Idraparinuks (sanorg 34006) za zdravljenje in sekundarno profilakso venskih tromboembolicnih profilakso venskih tromboembolicnih dogodkov pri pacientih z globoko vensko trombozo
GB0115707D0 (en)	2001-08-22	Treatment and prevention of lipodermatosclerosis
GB9922752D0 (en)	1999-11-24	Medical devices and treatment and prophylaxis
AU2003259202A8 (en)	2004-02-09	Compositions and methods for treating and preventing infection
EP1472273A4 (en)	2005-01-26	COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
IL162941A0 (en)	2005-11-20	Carboxamidine derivatives and their use in the treatment of vascular diseases
AU6746501A (en)	2001-12-11	Methods for prevention of ulcers and improving physiological performance
AU2003219880A8 (en)	2003-09-09	Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
EP1284746A4 (en)	2005-03-16	TREATMENT AND PREVENTION
EP1696918A4 (en)	2008-12-31	METHOD FOR THE TREATMENT OF HIV INFECTIONS IN PATIENTS WITH ATAZANAVIR RESISTANCE USING A COMBINATION OF ATAZANAVIR AND ANOTHER PROTEASE INHIBITOR
GB2399500B (en)	2006-07-05	Composition and method for treatment of wounds
EP1583543A4 (en)	2009-09-09	METHOD AND THERAPEUTIC COMPOSITIONS IN THE TREATMENT OF ADVANCED CARCINOMA
AU2003225191A8 (en)	2003-11-17	Methods useful in treatment and prevention of hiv infection
AU2003292354A8 (en)	2004-05-04	Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults

Legal Events

Date	Code	Title	Description
2011-09-30	RECP	Rectifications of patent specification